Duke scholars shared their expertise with local and national media on some of the biggest stories of the week 鈥 including President Trump鈥檚 challenges to election results, optimism for a potential coronavirus vaccine and another legal challenge to the Affordable Care Act. Read their comments below.
For daily media coverage featuring Duke people and research, visit the site.
THE CHARLOTTE OBSERVER
Features comments from a Duke news briefing with political science professor Peter Feaver and Sanford School professor Bruce Jentleson. Feaver previously worked in the Clinton and George W. Bush administrations, and Jentleson worked at the State Department and on presidential campaigns for Democrats Al Gore and Barack Obama.
WRAL
Dr. Cameron Wolfe, an infectious disease specialist at 老牛影视 Hospital, is among the 44,000 people who enrolled in Pfizer's clinical trials of a potential coronavirus vaccine. 鈥淚t just seemed like the right thing to do, frankly," Wolfe said. Pfizer announced Monday that the vaccine candidate had a 90 percent efficacy rate.
WRAL
Duke university law professor Neil Siegel said he expects the Affordable Care Act to survive another legal challenge at the U.S. Supreme Court. The court heard arguments for a third time this week on whether to invalidate the act.
THE WALL STREET JOURNAL
These include a criminal investigation in Manhattan, a New York state attorney general civil probe into alleged fraud and multiple lawsuits. 鈥淎t some point, it鈥檚 conceivable it will catch up to him,鈥 said Duke Law School professor Lisa Kern Griffin, though she added that a criminal prosecution of a former president is unlikely.
CNBC
The Centers for Disease Control and Prevention has highlighted another benefit of mask-wearing: Masks can also protect the wearer from other people鈥檚 droplets. This story cites a Duke study showing that surgical face masks made from polypropylene are the most effective at filtering out particles.